InspireMD Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 5, 2025
---
Management to host investor conference call today, August 5th, at 8:30am ET
---
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the second quarter and six months ended June 30, 2025.
Read more at globenewswire.comNASDAQ:NSPR (10/9/2025, 9:30:57 PM)
2.4
-0.04 (-1.44%)
Find more stocks in the Stock Screener
